Keros Therapeutics Inc Earnings

The next earnings date for Keros Therapeutics Inc is October 30, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Keros Therapeutics Inc Earnings

Report Date	Estimated Earnings Per Share
10/30/2025	$-1

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Keros Therapeutics Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
07/31/2025	---	$0	100.00%
05/06/2025	Before Market	$3.62	48,166.67%
02/26/2025	Before Market	$-1.14	-166.98%
11/04/2024	Before Market	$-1.41	-10.16%
08/06/2024	Before Market	$-1.25	-1.63%
05/08/2024	Before Market	$-1.21	10.37%
02/28/2024	After Market	$-1.34	2.19%
11/06/2023	Before Market	$-1.33	1.48%
08/07/2023	Before Market	$-1.27	5.22%
05/04/2023	After Market	$-1.26	-12.50%
03/03/2023	After Market	$-1.09	0.91%
11/03/2022	Before Market	$-0.92	25.20%
08/04/2022	After Market	$-1.13	-6.60%
05/05/2022	Before Market	$-1.01	-17.44%
03/09/2022	After Market	$-0.30	67.39%
11/04/2021	Before Market	$-0.87	-20.83%
08/05/2021	After Market	$-0.67	-3.08%
05/06/2021	After Market	$-0.68	-17.24%
03/25/2021	Before Market	$-0.49	14.04%
11/10/2020	After Market	$-0.60	-1.69%
08/13/2020	Before Market	$-0.62	7.46%
05/22/2020	Before Market	$-5.11	-1,281.08%

More About Keros Therapeutics Inc

Website

https://www.kerostx.com

Country

USA

Full Time Employees

148

Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes novel therapeutics for patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta family of proteins in the United States. The company's lead product candidate is KER-050, which is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia in patients with myelodysplastic syndromes, as well as in patients with myelofibrosis. It also develops KER-012, which is in Phase II clinical trial to treat pulmonary arterial hypertension and cardiovascular disorders; and KER-065 that is in Phase I clinical trial for the treatment neuromuscular diseases. The company has collaboration and license agreement with Hansoh (Shanghai) Healthtech Co., Ltd. to develop, manufacture, and commercialize elritercept and licensed products containing elritercept. Keros Therapeutics, Inc. was incorporated in 2015 and is headquartered in Lexington, Massachusetts.

“Keros Therapeutics Inc Earnings” Can Refer to the Keros Therapeutics Inc Earnings Date

Some people say “Keros Therapeutics Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Keros Therapeutics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Keros Therapeutics Inc Stock on the Earnings Date

If you own Keros Therapeutics Inc stock (KROS) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Keros Therapeutics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Keros Therapeutics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Keros Therapeutics Inc Earnings

You can contact us any time if you would like to ask questions about Keros Therapeutics Inc earnings or anything else related to the stock market.